Article

Phakic IOL preserves endothelial cell count outcome measure

Study shows cell loss equal to natural aging, allowing IOL to be implanted in young patients

Related Videos
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
Image credit: ©Ophthalmology Times
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Wendy Lee, MD, talks about functional oculoplastics and aesthetics at EnVision Summit 2025
Related Content
Study reveals temperature fluctuations at home may compromise anti-VEGF drug safety
January 22nd 2025

Study reveals temperature fluctuations at home may compromise anti-VEGF drug safety

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Sling Therapeutics announces topline efficacy and safety data from Phase 2b/3 LIDS trial on linsitinib
January 21st 2025

Sling Therapeutics announces topline efficacy and safety data from Phase 2b/3 LIDS trial on linsitinib

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Glaukos announces several positive clinical updates for its iDose platform
January 20th 2025

Glaukos announces several positive clinical updates for its iDose platform

Rayner launches redesign of IOL calculator RayTrace
January 20th 2025

Rayner launches redesign of IOL calculator RayTrace

© 2025 MJH Life Sciences

All rights reserved.